These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27268651)

  • 1. Combination of Potassium Pentagamavunon-0 and Doxorubicin Induces Apoptosis and Cell Cycle Arrest and Inhibits Metastasis in Breast Cancer Cells.
    Putri H; Jenie RI; Handayani S; Kastian RF; Meiyanto E
    Asian Pac J Cancer Prev; 2016; 17(5):2683-8. PubMed ID: 27268651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin and its analogues (PGV-0 and PGV-1) enhance sensitivity of resistant MCF-7 cells to doxorubicin through inhibition of HER2 and NF-kB activation.
    Meiyanto E; Putri DD; Susidarti RA; Murwanti R; Sardjiman ; Fitriasari A; Husnaa U; Purnomo H; Kawaichi M
    Asian Pac J Cancer Prev; 2014; 15(1):179-84. PubMed ID: 24528023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation.
    Meiyanto E; Putri H; Arum Larasati Y; Yudi Utomo R; Istighfari Jenie R; Ikawati M; Lestari B; Yoneda-Kato N; Nakamae I; Kawaichi M; Kato JY
    Adv Pharm Bull; 2019 Aug; 9(3):445-452. PubMed ID: 31592109
    [No Abstract]   [Full Text] [Related]  

  • 4. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
    Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence.
    Lestari B; Nakamae I; Yoneda-Kato N; Morimoto T; Kanaya S; Yokoyama T; Shionyu M; Shirai T; Meiyanto E; Kato JY
    Sci Rep; 2019 Oct; 9(1):14867. PubMed ID: 31619723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Analog Pentagamavunon-1 (PGV-1) Sensitizes Widr Cells to 5-Fluorouracil through Inhibition of NF-κB Activation.
    Meiyanto E; Septisetyani EP; Larasati YA; Kawaichi M
    Asian Pac J Cancer Prev; 2018 Jan; 19(1):49-56. PubMed ID: 29373892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tylophorine Abrogates G2/M Arrest Induced by Doxorubicine and Promotes Increased Apoptosis in T47D Breast Cancer Cells.
    Pratama NP; Wulandari S; Nugroho AE; Fakhrudin N; Astuti P; Sudarsono
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3065-3069. PubMed ID: 30485942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-deoxy-D-Glucose Synergizes with Doxorubicin or L-Buthionine Sulfoximine to Reduce Adhesion and Migration of Breast Cancer Cells.
    Mustafa EH; Mahmoud HT; Al-Hudhud MY; Abdalla MY; Ahmad IM; Yasin SR; Elkarmi AZ; Tahtamouni LH
    Asian Pac J Cancer Prev; 2015; 16(8):3213-22. PubMed ID: 25921122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins.
    Musyayyadah H; Wulandari F; Nangimi AF; Anggraeni AD; Ikawati M; Meiyanto E
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2929-2938. PubMed ID: 34582664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells.
    Nurhayati IP; Khumaira A; Ilmawati GPN; Meiyanto E; Hermawan A
    Asian Pac J Cancer Prev; 2020 May; 21(5):1259-1267. PubMed ID: 32458631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of ethyl acetate fraction of Ficus septica Burm. f. and doxorubicin chemotherapy on T47D human breast cancer cell line.
    Nugroho AE; Hermawan A; Putri D P; Meiyanto E; Hakim L
    Zhong Xi Yi Jie He Xue Bao; 2012 Oct; 10(10):1162-70. PubMed ID: 23073201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells.
    Amalina ND; Salsabila IA; Zulfin UM; Jenie RI; Meiyanto E
    J Egypt Natl Canc Inst; 2023 Mar; 35(1):6. PubMed ID: 36967442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
    Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
    Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
    Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
    Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.
    Meiyanto E; Husnaa U; Kastian RF; Putri H; Larasati YA; Khumaira A; Pamungkas DDP; Jenie RI; Kawaichi M; Lestari B; Yokoyama T; Kato JY
    Adv Pharm Bull; 2021 Jan; 11(1):188-196. PubMed ID: 33747866
    [No Abstract]   [Full Text] [Related]  

  • 19. Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone.
    El-Far AH; Darwish NHE; Mousa SA
    Integr Cancer Ther; 2020; 19():1534735419901160. PubMed ID: 32054357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
    Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
    Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.